GlassScriptPhysician profile
Nicholas P Athas
NPI 1891945887
$1,775.02
in general payments reported to CMS, 2019-2025
26 companies · $396 in 2025
The $396 reported for 2025 was more than what 76% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2022: $444 · 2023: $222 · 2024: $471 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $463.34 | 2021-2025 | Enseal, Echelon Flex, Ethicon |
| Abbvie INC. | $307.43 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $162.65 | 2021-2025 | Keytruda, Lynparza |
| Eisai INC. | $135.54 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $96.49 | 2021-2025 | Libtayo |
| Janssen Biotech, INC. | $66.25 | 2023-2025 | Tecvayli, Darzalex, Rybrevant |
| Novartis Pharmaceuticals Corporation | $42.11 | 2022-2023 | |
| Nestle Healthcare Nutrition INC. | $37.72 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $36.76 | 2022 | |
| Taiho Oncology, INC. | $35.03 | 2025 | |
| Integra Lifesciences Corporation | $33.76 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.66 | 2025 | |
| Tempus Ai, INC | $28.14 | 2024 | Xt Cdx |
| C. R. Bard, INC. & Subsidiaries | $27.29 | 2023 | Arista Ah Flexitip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.81 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $26.70 | 2022 | |
| Pharmacosmos Therapeutics INC. | $26.29 | 2022 | |
| Digestive Care, INC. | $25.99 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $23.85 | 2024 | Somatuline Depot, Onivyde |
| Caris Mpi, INC. | $23.34 | 2025 | Mi Cancer Seek |
| Incyte Corporation | $22.56 | 2022 | |
| Angiodynamics, INC. | $22.51 | 2025 | Smart Port Ct |
| Pharmaessentia USA Corporation | $20.61 | 2025 | Besremi |
| Lilly USA, LLC | $20.46 | 2024 | Jaypirca, Verzenio |
| Qol Medical, LLC | $19.30 | 2024 | Sucraid |
| Hologic Sales and Service, LLC | $14.43 | 2024 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Athas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.